Startling new research was published in the Journal of American Academy of Dermatology this month, says Newswise. The research, conducted by the University of Arkansas Medical Sciences’ Appathurai Balamurugan, M.D., M.P.H., stated that survivors of melanoma were more likely to contract melanoma again, as well as other forms of cancer, than other members of the general public.
The study was the first of its kind to estimate the risk of new cancers among people with in situ (noninvasive) melanoma using such a large sample size: 40,881 people. It found that even when diagnosed early, women melanoma survivors were 12 times more likely to develop invasive melanoma, and men survivors were eight times more likely.
People were studied between 1992 and 2006 for this study. The data for the study came from the National Cancer Institute Surveillance Epidemiology and End Results Program. Balamurugan points out that, “the higher incidence for women… is probably a result of increased time spent outdoors and the use of tanning beds”. He also says that why the average age for woman contracting melanoma is currently in the 50s, the age is rapidly dropping into the 40s, and even 30s.
The article points out that, “the stakes are high… because an estimated 70,230 people in the United States will be diagnosed with melanoma, and an estimated 8,760 people will die due to melanoma in 2011″. As for other forms of cancer, the percentages of melanoma survivors contracting these forms were also shockingly high.
For survivors of an in situ (noninvasive early stage) melanoma, their risk of getting lymphocytic leukemia was 44 percent higher for men and 79 percent for women. Men and women survivors of an invasive melanoma also were at higher risk for thyroid cancer (about twice as likely), non-Hodgkin’s lymphoma (about 50 percent more likely) and chronic lymphocytic leukemia (about 60 percent).
The article states that researchers hope that these findings force physicians to become more aggressive in their screening for melanoma. They also hope that doctors will be better at educating their patients about the dangers of this cancer. All it takes is a simple shift in behavior to prevent melanoma. If the public can make this more apparent, we would see a fall in the cases of this cancer. MoleSafe is trying to do just this!





